MedTrace Logo

The Role of Gut Hormones and Hepcidin in Type 2 Diabetes Mellitus

NCT02413762 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1512

Last updated 2023-06-01

No results posted yet for this study

Summary

This study aims to investigate the potential of the gut hormones GLP-1, PP, PYY and the iron regulatory hormone hepcidin as biomarkers for progression to complications in diabetes mellitus.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Imperial College London Diabetes Centre

    lead OTHER

Principal Investigators

  • Nader Lessan, MBBS FRCP MD · Imperial College London Diabetes Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-08-31
Completion
2022-10-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02413762 on ClinicalTrials.gov